Provention Bio
Research-driven biopharmaceutical company engaged in discovery, development and large-scale manufacturing of medicines and vaccines. Operates domestic biologics and vaccine production facilities, maintains serialization and supply-chain traceability systems, provides patient access and support programs, and publishes patient- and community-focused content to support disease awareness, screening and advocacy.
Industries
N/A
Nr. of Employees
medium (51-250)
Patents
Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity
US-9056906-B2
View DetailsMethods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity
US-8663634-B2
View Details
Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity
US-9056906-B2
View DetailsMethods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity
US-8663634-B2
View DetailsProducts
Prescription medicines (multiple therapeutic areas)
A portfolio of prescription medicines across therapeutic areas including immunology, neurology, oncology, rare blood disorders, rare diseases, cardiovascular disease, diabetes and transplant.
Vaccines and immunization products
Vaccine products and immunization solutions intended to protect population health across life stages and for emerging epidemics.
Prescription medicines (multiple therapeutic areas)
A portfolio of prescription medicines across therapeutic areas including immunology, neurology, oncology, rare blood disorders, rare diseases, cardiovascular disease, diabetes and transplant.
Vaccines and immunization products
Vaccine products and immunization solutions intended to protect population health across life stages and for emerging epidemics.
Services
Programs to reduce out-of-pocket costs, provide copay assistance and supply free medicine to eligible patients; includes a centralized patient support navigation service.
Evidence-based product information and adverse-event reporting support for healthcare professionals.
Provision of lot- and serial-level traceability data via portal access, EPCIS feeds, and verification services to authorized trading partners.
Programs to reduce out-of-pocket costs, provide copay assistance and supply free medicine to eligible patients; includes a centralized patient support navigation service.
Evidence-based product information and adverse-event reporting support for healthcare professionals.
Provision of lot- and serial-level traceability data via portal access, EPCIS feeds, and verification services to authorized trading partners.
Expertise Areas
- Vaccine development and manufacturing
- Large-scale biologics production
- AI-enabled research and manufacturing optimization
- Clinical trial design with community engagement
Key Technologies
- mRNA platform development
- Recombinant biologics manufacturing
- Vaccine formulation and sterile filling
- Mass spectrometry
News & Updates
Management reviewed Q2 2026 financial results in a live audio webcast followed by Q&A on July 30, 2026.
U.S. approval announced for a therapy described as disease-modifying for patients recently diagnosed with stage 3 type 1 diabetes.
Announcement of U.S. approval for a subcutaneous anticancer treatment administered via an on-body injector device.
Company announced it would not submit a specified therapy for global regulatory reviews.
Article exploring a telehealth-enabled platform designed to request type 1 diabetes screening.
Patient-centered story about how risk for type 1 diabetes affects a family.
Management reviewed Q2 2026 financial results in a live audio webcast followed by Q&A on July 30, 2026.
U.S. approval announced for a therapy described as disease-modifying for patients recently diagnosed with stage 3 type 1 diabetes.
Announcement of U.S. approval for a subcutaneous anticancer treatment administered via an on-body injector device.
Company announced it would not submit a specified therapy for global regulatory reviews.
Article exploring a telehealth-enabled platform designed to request type 1 diabetes screening.
Patient-centered story about how risk for type 1 diabetes affects a family.